The University of Texas System

Ridgeback To Lead Development Of Emory University Viral Replication Inhibitor Privately held Ridgeback Biotherapeutics LP and Emory University y announced on 19 March they will work together to advan

ReCode Therapeutics and TranscripTx have combined their development of RNA-based medicines under one banner, emerging under the ReCode banner with $80m in series A venture capital to complete precl

Below is Scrip’s regular roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Spherix

South San Francisco startup Tenaya Therapeutics Inc. has ambitious plans to advance three drug development platforms for cardiovascular disease: cell therapy, gene therapy and small molecule precisi